Harbin Medisan Pharmaceutical Co Ltd (002900) — Capital Reinvestment Ratio
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Capital Reinvestment Ratio of 0.79x as of March 2025, meaning it reinvests 1% of its operating cash flow (CN¥86.31 Million) in capital expenditures (CN¥68.40 Million). See 002900 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Medisan Pharmaceutical Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Harbin Medisan Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Harbin Medisan Pharmaceutical Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see market value of Harbin Medisan Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 11.28x | CN¥30.69 Million | CN¥346.21 Million | ▲ +34.4% |
| 2023 | 8.39x | CN¥35.69 Million | CN¥299.58 Million | ▲ +1260.6% |
| 2022 | 0.62x | CN¥144.64 Million | CN¥89.22 Million | ▼ -0.6% |
| 2019 | 0.62x | CN¥320.14 Million | CN¥198.63 Million | ▲ +131.4% |
| 2018 | 0.27x | CN¥292.46 Million | CN¥78.41 Million | ▼ -42.9% |
| 2017 | 0.47x | CN¥223.46 Million | CN¥104.93 Million | ▲ +15.6% |
| 2016 | 0.41x | CN¥231.18 Million | CN¥93.88 Million | ▼ -42.4% |
| 2015 | 0.71x | CN¥200.85 Million | CN¥141.72 Million | ▼ -43.7% |
| 2014 | 1.25x | CN¥116.31 Million | CN¥145.81 Million | ▲ +35.9% |
| 2013 | 0.92x | CN¥167.10 Million | CN¥154.13 Million | ▲ +24.9% |
| 2012 | 0.74x | CN¥123.22 Million | CN¥91.01 Million | — |